Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Novartis BrasilNovartis Brasil
VS
SUN PHARMASUN PHARMA
Novartis Brasil

Novartis Brasil

undefined, São Paulo, São Paulo, 04605-000, BR

Last Update: 01/02/2026

View Profile
Between 750 and 799
https://www.novartis.com.br/
758/1000Fair

A Novartis está reimaginando a medicina para melhorar e estender a vida das pessoas. Como líder mundial em medicamentos, usamos ciência inovadora e tecnologias digitais para criar tratamentos transformadores em áreas médicas de grande impacto. Em nossa busca por novos m...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:346
Subsidiaries:43
12-month incidents
0
Known data breaches
0
Attack type number
0
SUN PHARMA

SUN PHARMA

Sun House, CTS No. 201 B/1,, Mumbai, 400063, IN

Last Update: 12/09/2026

View Profile
Between 800 and 849
http://www.sunpharma.com
811/1000Good

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufa...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:44,544
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Novartis Brasil

Novartis Brasil

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
SUN PHARMA

SUN PHARMA

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Brasil in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for SUN PHARMA in 2026.

Incidents

Incident History - Novartis Brasil (X = Date, Y = Severity)

Novartis Brasil cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - SUN PHARMA (X = Date, Y = Severity)

SUN PHARMA cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Novartis Brasil

Novartis Brasil

Incidents
No explicit notable incidents reported.
SUN PHARMA

SUN PHARMA

Incidents
No explicit notable incidents reported.

FAQ

Between Novartis Brasil company and SUN PHARMA company, which one has the best AI Cybersecurity Score ?
Between Novartis Brasil company and SUN PHARMA company, which one has experienced more cyber incidents in the past ?
Between Novartis Brasil company and SUN PHARMA company, which one has experienced more cyber incidents this year ?
Between Novartis Brasil company and SUN PHARMA company, which one has experienced at least one ransomware attack ?
Between Novartis Brasil company and SUN PHARMA company, which one has experienced at least one data breach ?
Between Novartis Brasil company and SUN PHARMA company, which one has experienced at least one targeted cyberattack ?
Between Novartis Brasil company and SUN PHARMA company, which one has experienced at least one vulnerability ?
Between Novartis Brasil company and SUN PHARMA company, which one holds the most compliance certifications ?
Between Novartis Brasil company and SUN PHARMA company, which one holds the fewest compliance certifications ?
Between Novartis Brasil company and SUN PHARMA company, which one has the most subsidiaries ?
Between Novartis Brasil company and SUN PHARMA company, which one has the largest number of employees ?
Between Novartis Brasil and SUN PHARMA, which company holds both SOC 2 Type 1 certifications ?
Between Novartis Brasil and SUN PHARMA, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Novartis Brasil or SUN PHARMA ?
Which company is PCI DSS compliant - Novartis Brasil or SUN PHARMA ?
Between Novartis Brasil and SUN PHARMA, which company complies with HIPAA regulations for healthcare data ?
Between Novartis Brasil and SUN PHARMA, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-96451
SUMMARY

Authorization Bypass Through User-Controlled Key vulnerability in Ultimate Member Ultimate Member ultimate-member allows Privilege Escalation.This issue affects Ultimate Member: from n/a through 2.13.1.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-103342
SUMMARY

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Unlimited Elements Unlimited Elements For Elementor (Free Widgets, Addons, Templates) unlimited-elements-for-elementor allows Reflected XSS.This issue affects Unlimited Elements For Elementor (Free Widgets, Addons, Templates): from n/a through 2.0.20.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-103065
SUMMARY

Improper Validation of Specified Quantity in Input vulnerability in Themeum Kirki kirki allows Accessing Functionality Not Properly Constrained by ACLs.This issue affects Kirki: from n/a through 6.3.1.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 8.2)
CVSS3
Base Score: 8.2
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N
IMPACT SCORE
4.2
EXPLOITABILITY
3.9
REFERENCES
CVE-2026-105122
SUMMARY

OpenAM before 16.1.3 contains a server-side request forgery vulnerability that allows attackers able to register or modify OAuth 2.0 clients to make OpenAM fetch internal resources via an unvalidated jwks_uri. Attackers can trigger unauthenticated fetches through client-authentication and ID-token validation to probe internal hosts, metadata endpoints or local files, or exhaust request threads for denial of service.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 5.4)
CVSS3
Base Score: 5.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.5
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-105121
SUMMARY

OpenAM before 16.1.3 contains an improper authorization vulnerability that allows delegated administrators to destroy sessions outside their realms because realm checks use the requester's realm. Authenticated accounts holding the iplanet-am-session-destroy-sessions attribute can supply a target session identifier or handle to forcibly log out users in any realm.

PUBLISHED
Date2026-10-03
UPDATED
Date2026-10-03
RISK INFORMATION (Score: 4.9)
CVSS3
Base Score: 4.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H
CVSS4
Base Score: 6.9
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
REFERENCES